METHOD FOR ASSESSING THE CLINICAL EFFECTIVENESS OF UROGENITAL CLAMIDIOSIS Russian patent published in 2019 - IPC G01N33/48 

FIELD: medicine.

SUBSTANCE: method consists in the fact that a patient with a generalized form of chronic urogenital clamidiosis 10–14 days after the antichlamydia treatment is diagnosed in a phagocytosis reaction using the peripheral blood leuco-concentrate of the patient, suspensions of strains of Staphylococcus aureus 209 P and Escherichia coli 14169 phagocytic neutrophil indices measured 30 and 120 minutes from the beginning of the phagocytosis reaction, then formulas F1 and F2 are calculated, further obtained by formulas values F1 and F2 are rounded to the second decimal place and the presence of the effect of treating the generalized form of chronic urogenital clamidiosis if the value of F2 is greater than the value F1, or the absence of the effect of treating the generalized form of chronic urogenital clamidiosis if the F1 value is greater than the value F2, or the clinical effectiveness of the urogenital clamidiosis is repeatedly assessed if the value F1 is equal to the value F2.

EFFECT: invention can be used for assessing the clinical effectiveness of the generalized form of chronic urogenital Chlamydia caused by Chlamydia trachomatis.

1 cl, 4 ex